Artemisia annua amorpha-4,11-diene synthase mutant with improved enzyme activity and application thereof
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- CAS CENT FOR EXCELLENCE IN MOLECULAR PLANT SCI
- Publication Date
- 2014-07-16
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the field of biotechnology; more specifically, the invention relates to a mutant of Artemisia amorphadiene synthase with improved enzyme activity and application thereof. Background technique
[0002] Artemisinin is a peroxybridge-containing sesquiterpene lactone isolated and identified for the first time by Chinese scientists from Artemisia annua. It is currently the most effective drug for the treatment of cerebral malaria and chloroquine-resistant falciparum malaria. Artemisinin-based combined therapy has been confirmed and recommended by the World Health Organization and Western countries. The content of artemisinin in Artemisia annua is low (0.01-1% dry weight), and it is greatly affected by species and regional planting, and resources are in short supply.
[0003] In the biosynthesis of artemisinin, the sesquiterpene component amorphadiene (Amorphadiene, Amorpha-4, 11-diene) is synthesized by the amorphadiene synthase (a...